GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | 13.21 | 8.19 | 4.31 | 5.79 | 8.35 |
What is the latest Core EBITDA Margin ratio of GLENMARK PHARMACEUTICALS ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2026 | 13.21 |
| Mar2025 | 8.19 |
| Mar2024 | 4.31 |
| Mar2023 | 5.79 |
| Mar2022 | 8.35 |
How is Core EBITDA Margin of GLENMARK PHARMACEUTICALS Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2026 | 13.21 | 61.29 | |
| Mar2025 | 8.19 | 90.02 | |
| Mar2024 | 4.31 | -25.56 | |
| Mar2023 | 5.79 | -30.66 | |
| Mar2022 | 8.35 | - | |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹65,131.8 Cr | 3.5% | -3.6% | 28.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3.5% |
-3.6% |
28.3% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses